About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 857 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 857 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 857 trials

CompletedDose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate CancerThis Phase I, open-label, dose-finding, multicenter study is designed to determine the recommended Phase II dose (RP2D) for the combination of an orally administered…NCT02215096·Duarte, California and 8 others CompletedA Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of CancerThis study is to evaluate diagnostic performance, safety and timing of post-dose imaging of ONM-100, an intraoperative fluorescence imaging agent for the detection of cancer in…NCT03735680·Philadelphia, Pennsylvania and 2 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486Population pharmacokinetic and pharmacodynamic data from Study FE200486 CS06 and FE200486 CS02 provided further knowledge of the optimal dose regimens for FE200486 (degarelix).NCT00117949·Anaheim, California and 11 others

CompletedDetermine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of EnzalutamideThis study is being conducted to determine the effect of enzalutamide on the androgen signaling pathway in correlation with the anti-tumor effects of enzalutamide to identify…NCT01091103·Houston, Texas

RecruitingPRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.To look at the safety and effectiveness of stereotactic body radiation therapy (SBRT) in treating advanced or high-risk prostate cancer.NCT06369246·Houston, Texas

TerminatedA Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.A first-in-human clinical trial to test the investigational treatment ONCT-534 in participants with metastatic castration-resistant prostate cancer.NCT05917470·San Francisco, California and 9 others

RecruitingNeoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerThis is a Phase I/II trial evaluating the effectiveness of adding neoadjuvant HDR-B prior to RALP for HR-PCa patients with selective AAB for decipher high risk or pathologically…NCT07182279·Houston, Texas

RecruitingA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC…NCT06629779·Chandler, Arizona and 232 others

CompletedQuestionnaire and Fall Risk AssessmentThe goal of this research study is to learn if your answers to questions during an interview can help researchers predict how well you function physically and if you are at a high…NCT00836238·Houston, Texas

TerminatedLong-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerThis is a long-term prospective registry study to determine whether Prolaris testing in patients with favorable intermediate risk prostate cancer influences physician management…NCT03290508·Homewood, Alabama and 33 others

Completed131-I-TM-601 Study in Adults With Solid TumorsThis study is designed to evaluate the ability of intravenously (IV)administered 131-I-labeled TM-601 (chlorotoxin) to provide tumor-specific localization(via radiographic…NCT00379132·Birmingham, Alabama and 5 others

CompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate CancerThe purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to…NCT03085095·Tucson, Arizona and 161 others

CompletedStockholm3 Validation Study in a Multi-Ethnic CohortIntroduction: Prostate cancer (PCa) is the most commonly detected cancer in men and is the second leading cause of cancer death.NCT04583072·Los Angeles, California and 13 others

Active not recruitingBrachytherapy for Prostatic Carcinoma PatientsThe goal of this clinical research study is to learn if a prostate implant (brachytherapy) can help to control intermediate risk prostate cancer.NCT00525720·Houston, Texas

CompletedAn Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid TumorsTo determine the feasibility and safety of administering YM155 in combination with docetaxelNCT00514267·San Antonio, Texas

Active not recruitingStereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate CancerSince high risk prostate cancer requires higher radiation, this study is being done to determine the maximum tolerated dose of radiation to the prostate and pelvic regions.NCT02353819·Dallas, Texas

Active not recruitingA Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerThe purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.NCT03574571·Gilbert, Arizona and 71 others

Active not recruitingRadiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialThis phase II trial studies how well radiation therapy with or without apalutamide works in treating patients with prostate cancer that has come back (recurrent).NCT03371719·Gilbert, Arizona and 359 others

WithdrawnDocetaxel Followed by Provenge in Metastatic Prostate CancerThis clinical study will evaluate the role of combination therapy of docetaxel followed by Provenge for patients with metastatic castration-resistant prostate cancer (CRPC…NCT02793765·Houston, Texas

CompletedDaratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate CancerThis phase I trial studies the side effects of daratumumab or FMS inhibitor JNJ-40346527 before surgery in treating patients with high-risk prostate cancer that can be removed by…NCT03177460·Houston, Texas

PreviousPage 5 of 43Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma